NCT00110786View on ClinicalTrials.gov

Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy

PHASE2CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

December 31, 2005

Conditions
Type I Hypersensitivity
Interventions
BIOLOGICAL

Ragweed MATAMPL

Trial Locations (1)

L4W 1N2

Allied Research International Inc., Mississauga

Sponsors
All Listed Sponsors
lead

Allergy Therapeutics

INDUSTRY